Results of a Phase I-II Study of Fenretinide and Rituximab for Patients with B-Cell Lymphomas

被引：0
作者：
Cowan, Andrew J. [1 ]
Stevenson, Philip [2 ]
Gooley, Ted A. [2 ]
Frayo, Shani L. [2 ]
Oliveira, George R. [3 ]
Smith, Stephen D. [1 ,4 ]
Green, Damian J. [1 ,2 ]
Roden, Jennifer E. [5 ]
Pagel, John M. [6 ]
Wood, Brent L. [4 ,7 ]
Press, Oliver W. [1 ,4 ]
Gopal, Ajay K. [1 ,8 ]
机构：
[1] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA
[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[3] Harvard Univ, Sch Med, Dept Radiol, MGH Hosp, Boston, MA 02115 USA
[4] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA
[5] Univ Washington, Dept Med, Seattle, WA USA
[6] Swedish Med Ctr, Seattle, WA USA
[7] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA
[8] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] B-cell lymphomas: therapeutic results
    Brice, Pauline
    Salles, Gilles
    HEMATOLOGIE, 2007, 13 : 24 - 27
  • [32] A Phase II Study of MLN8237 (Alisertib) Alone and in Combination with Rituximab in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas (NHL)
    Maddocks, Kami J.
    Cohen, Jonathon B.
    Christian, Beth
    Flynn, Joseph M.
    Jaglowski, Samantha M.
    Blum, Kristie A.
    BLOOD, 2014, 124 (21)
  • [33] Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma
    Tobinai, K
    Igarashi, T
    Itoh, K
    Kobayashi, Y
    Taniwaki, M
    Ogura, A
    Kinoshita, T
    Hotta, T
    Aikawa, K
    Tsushita, K
    Hiraoka, A
    Matsuno, Y
    Nakamura, S
    Morio, S
    Ohashi, Y
    ANNALS OF ONCOLOGY, 2004, 15 (05) : 821 - 830
  • [34] A phase II study of Zanubrutinib in combination with rituximab in patients with relapsed/refractory aggressive and indolent B-cell lymphoma
    Qingyuan Zhang
    Rong Tao
    Zhenyu Li
    Haiyi Guo
    Meng Ji
    Lu Zhang
    Jane Huang
    Fu Lina
    Jinhua Zhong
    Jianfeng Zhou
    LEUKEMIA & LYMPHOMA, 2022, 63 (10) : 2503 - 2506
  • [35] A Phase I Study of Selinexor and R-ICE in Patients with Relapsed/Refractory Aggressive B-Cell Lymphomas
    Rutherford, Sarah C.
    Allan, John N.
    Ruan, Jia
    Furman, Richard R.
    Richards, Kristy
    Rodriguez, Amelyn
    Gololobova, Kseniya
    Garcia, Arcania
    Cerchietti, Leandro
    Marullo, Rossella
    Chen, Zhengming
    Santamala, Jennifer
    Shore, Tsiporah B.
    Phillips, Adrienne A.
    Mayer, Sebastian
    Hsu, Jingmei
    Gergis, Usama
    Senese, Silvia
    Ali-Shaw, Trisha
    Rahim, Riyaad
    van Besien, Koen
    Leonard, John P.
    Martin, Peter
    BLOOD, 2020, 136
  • [36] Primary cutaneous B-Cell Lymphomas: Intralesional Rituximab Therapy
    Kilikidou, E.
    Nestoris, S.
    Keiler, A.
    Khojah, A.
    El Marakby, A.
    Lohbeck, A.
    Stege, H.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 60 - 60
  • [37] The expanding role of rituximab and radioimmunotherapy in the treatment of B-cell lymphomas
    Jacobs, Samuel A.
    Foon, Kenneth A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (11) : 1749 - 1762
  • [38] Clinical status and optimal use of rituximab for B-cell lymphomas
    McLaughlin, P
    White, CA
    Grillo-López, AJ
    Maloney, DG
    ONCOLOGY-NEW YORK, 1998, 12 (12): : 1763 - 1769
  • [39] FIRST-LINE TREATMENT WITH RITUXIMAB AND BENDAMUSTINE IN OLD PATIENTS (80 YEARS AND OLDER) WITH AGGRESSIVE B-CELL LYMPHOMAS - AN INTERIM ANALYSIS OF AN ONGOING PHASE II STUDY
    Weidmann, E.
    Fauth, F.
    Atmaca, A.
    Al-Batran, S. E.
    Neumann, A.
    Pauligk, C.
    Jager, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 402 - 402
  • [40] Long-term follow-up of patients with HIV-related diffuse large B-cell lymphomas treated in a phase II study with rituximab and CHOP
    Ribera, Josep-Maria
    Morgades, Mireia
    Gonzalez-Barca, Eva
    Miralles, Pilar
    Lopez-Guillermo, Armando
    Gardella, Santiago
    Lopez, Andres
    Abella, Eugenia
    Garcia, Marta
    Navarro, Jose-Tomas
    Feliu, Evarist
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (05) : 637 - 639
12345